Skip to content

Star Health tanks as Q2 earnings miss estimate: Should you buy the Jhunjhunwala stock?

Star Health is set for a prolonged navigation through rough waters, where it will struggle to drive profitable growth, according to Emkay Global.

Read More

​ Star Health is set for a prolonged navigation through rough waters, where it will struggle to drive profitable growth, according to Emkay Global. Star Health is set for a prolonged navigation through rough waters, where it will struggle to drive profitable growth, according to Emkay Global.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish